4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-013284
EVP, COO, Head of Commercial sold 472 shares at $23.80 ($11,234)
- EVP, COO, Head of Commercial acquired 1,106 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, Head of Commercial | 2022-02-23 | Option exercise | +1,106 | 2,894 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2022-02-23 | Sale | −472 | $23.80 | $11,234 | 2,422 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, Head of Commercial | 2022-02-23 | Option exercise · Restricted Stock Units | +1,106 | 3,321 | D | ||
| Open-market sales · 472 sh · avg $23.80 · $11,234 | |||||||
Loading xslF345X03/doc4.xml…